208 related articles for article (PubMed ID: 9625639)
1. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
2. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
3. Managing patients with primary pulmonary hypertension: prostacyclin therapy.
Albert NM; Hague K
Am J Crit Care; 1997 Jul; 6(4):274-80. PubMed ID: 9215424
[No Abstract] [Full Text] [Related]
4. Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
Tuder RM; Zaiman AL
Am J Respir Cell Mol Biol; 2002 Feb; 26(2):171-4. PubMed ID: 11804866
[No Abstract] [Full Text] [Related]
5. Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
Sadushi-Koliçi R; Perthold W; Fruhwald FM; Lang IM
Eur J Clin Invest; 2008 Aug; 38(8):603-4. PubMed ID: 18573098
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
[TBL] [Abstract][Full Text] [Related]
7. Epoprostenol therapy for primary pulmonary hypertension.
Cheever KH; Kitzes B; Genthner D
Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension update.
Hesselgrave B
Case Manager; 2005; 16(6):61-6; quiz 67. PubMed ID: 16326325
[No Abstract] [Full Text] [Related]
9. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
10. Pulmonary hypertension--beyond vasodilator therapy.
Fishman AP
N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
[No Abstract] [Full Text] [Related]
11. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension.
Benvenuto DB
J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190
[TBL] [Abstract][Full Text] [Related]
12. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
13. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
15. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
16. Letter by Dias et al regarding article, "Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy".
Dias B; Jardim C; Souza R
Circulation; 2010 Jul; 122(1):e1. PubMed ID: 20606126
[No Abstract] [Full Text] [Related]
17. [Treatment of pulmonary artery hypertension].
Olschewski H; Seeger W
Pneumologie; 2000 Jun; 54(6):222-4. PubMed ID: 10934891
[No Abstract] [Full Text] [Related]
18. Inhaled prostacyclin: from pulmonary hypertension to splanchnic hypoperfusion.
Brienza N
Intensive Care Med; 1998 Nov; 24(11):1228-30. PubMed ID: 9876989
[No Abstract] [Full Text] [Related]
19. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol.
Kuhn KP; Byrne DW; Arbogast PG; Doyle TP; Loyd JE; Robbins IM
Am J Respir Crit Care Med; 2003 Feb; 167(4):580-6. PubMed ID: 12446266
[TBL] [Abstract][Full Text] [Related]
20. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]